- Home
- H vs ICLR Comparison
H vs ICLR Comparison
Compare H & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- H
- ICLR
- Stock Information
- Founded
- H 1957
- ICLR 1990
- Country
- H United States
- ICLR Ireland
- Employees
- H N/A
- ICLR N/A
- Industry
- H Hotels/Resorts
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- H Consumer Discretionary
- ICLR Health Care
- Exchange
- H Nasdaq
- ICLR Nasdaq
- Market Cap
- H 15.1B
- ICLR 16.4B
- IPO Year
- H 2009
- ICLR 1998
- Fundamental
- Price
- H $159.32
- ICLR $194.64
- Analyst Decision
- H Buy
- ICLR Strong Buy
- Analyst Count
- H 18
- ICLR 12
- Target Price
- H $156.25
- ICLR $283.45
- AVG Volume (30 Days)
- H 417.4K
- ICLR 966.3K
- Earning Date
- H 02-13-2025
- ICLR 02-19-2025
- Dividend Yield
- H 0.38%
- ICLR N/A
- EPS Growth
- H 192.44
- ICLR 44.49
- EPS
- H 13.18
- ICLR 8.99
- Revenue
- H $6,462,000,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- H $2.43
- ICLR $3.99
- Revenue Next Year
- H $4.03
- ICLR $2.19
- P/E Ratio
- H $11.97
- ICLR $21.75
- Revenue Growth
- H 4.01
- ICLR 3.63
- 52 Week Low
- H $125.45
- ICLR $183.38
- 52 Week High
- H $168.20
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- H 58.08
- ICLR 35.59
- Support Level
- H $153.34
- ICLR $192.93
- Resistance Level
- H $161.26
- ICLR $204.33
- Average True Range (ATR)
- H 3.05
- ICLR 6.25
- MACD
- H 0.43
- ICLR -0.73
- Stochastic Oscillator
- H 79.05
- ICLR 2.49
About H Hyatt Hotels Corporation
Hyatt is an operator of owned (4% of total rooms) and managed and franchised (96%) properties across around 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 54% Americas, 22% rest of world, and 23% Asia-Pacific.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.